The Miami International Evidence-based Guidelines on Minimally Invasive Pancreas Resection

Horacio J. Asbun, Alma Moekotte(University Hospital Southampton NHS Foundation Trust), Frederique L. Vissers(Amsterdam University Medical Centers), F. Kunzler, Federica Cipriani, Adnan Alseidi(Virginia Mason Medical Center), Michael I. D’Angelica(Memorial Sloan Kettering Cancer Center), Alberto Balduzzi(University of Verona), Claudio Bassi(University of Verona), Bergþór Björnsson(Linköping University), Ugo Boggi(University of Pisa), Mark P. Callery(Beth Israel Deaconess Medical Center), Marco Del Chiaro(University of Colorado Denver), Felipe José Fernández Coimbra(AC Camargo Hospital), Claudius Conrad(St. Elizabeth's Medical Center), Andrew Cook(University of Southampton), Alessandro Coppola(Agostino Gemelli University Polyclinic), Christos Dervenis(University of Cyprus), Safi Dokmak(Hôpital Beaujon), Barish H. Edil(Oklahoma City University), Bjørn Edwin(Oslo University Hospital), Pier Cristoforo Giulianotti(University of Illinois Urbana-Champaign), Ho‐Seong Han(Seoul National University Hospital), Paul D. Hansen(Providence Regional Medical Center Everett), Nicky van der Heijde(University Hospital Southampton NHS Foundation Trust), Jony van Hilst(Amsterdam University Medical Centers), Caitlin A. Hester(The University of Texas Southwestern Medical Center), Melissa E. Hogg(NorthShore University HealthSystem), Nicolás Jarufe(Pontificia Universidad Católica de Chile), D. Rohan Jeyarajah(Methodist Richardson Medical Center), Tobias Keck(University Hospital Schleswig-Holstein), Song Cheol Kim(Asan Medical Center), Igor Khatkov(Moscow Clinical Scientific Center), Norihiro Kokudo(National Center for Global Health and Medicine), David A. Kooby(Emory University), Maarten Korrel(Amsterdam University Medical Centers), Francisco J. de Leon(Hospital Regional Universitario de Málaga), Núria Lluís(Bellvitge University Hospital), Sanne Lof(University Hospital Southampton NHS Foundation Trust), Marcel Autran C. Machado(Universidade de São Paulo), Nicolas Demartines(University of Lausanne), John B. Martinie, Nipun B. Merchant(University of Miami), I. Quintus Molenaar(University Medical Center Utrecht), Cassadie Moravek(Pancreatic Cancer Action Network), Yiping Mou(Hangzhou Medical College), Masafumi Nakamura(Kyushu University), William H. Nealon(Northwell Health), Chinnusamy Palanivelu(Gastroenterology Medical Center and Hospital), Patrick Pessaux(Hôpital Civil, Strasbourg), Henry A. Pitt(Temple University), Patricio M. Polanco(The University of Texas Southwestern Medical Center), John N. Primrose(University Hospital Southampton NHS Foundation Trust), Arab Rawashdeh(University Hospital Southampton NHS Foundation Trust), Dominic E. Sanford(Barnes-Jewish Hospital), Palanisamy Senthilnathan(Gastroenterology Medical Center and Hospital), Shailesh V. Shrikhande(Tata Memorial Hospital), John Stauffer(Jacksonville College), Kyoichi Takaori(Kyoto University), Marina Talamonti(NorthShore University HealthSystem), Chung Ngai Tang(Pamela Youde Nethersole Eastern Hospital), Charles M. Vollmer(University of Pennsylvania), Go Wakabayashi(Hakodate Central General Hospital), R. Matthew Walsh(Cleveland Clinic), Shin-E Wang(National Yang Ming Chiao Tung University), Michael J. Zinner, Christopher L. Wolfgang(Johns Hopkins University), Amer H. Zureikat(University of Pittsburgh), M. Zwart(Amsterdam University Medical Centers), Kevin C. Conlon(Trinity College Dublin), Michael L. Kendrick(Mayo Clinic), Herbert J. Zeh(University of Pittsburgh), Mohammad Abu Hilal(University Hospital Southampton NHS Foundation Trust), Marc G. Besselink(Amsterdam University Medical Centers)
Annals of Surgery
September 22, 2019
Cited by 478Open Access
Full Text

Abstract

OBJECTIVE: The aim of this study was to develop and externally validate the first evidence-based guidelines on minimally invasive pancreas resection (MIPR) before and during the International Evidence-based Guidelines on Minimally Invasive Pancreas Resection (IG-MIPR) meeting in Miami (March 2019). SUMMARY BACKGROUND DATA: MIPR has seen rapid development in the past decade. Promising outcomes have been reported by early adopters from high-volume centers. Subsequently, multicenter series as well as randomized controlled trials were reported; however, guidelines for clinical practice were lacking. METHODS: The Scottisch Intercollegiate Guidelines Network (SIGN) methodology was used, incorporating these 4 items: systematic reviews using PubMed, Embase, and Cochrane databases to answer clinical questions, whenever possible in PICO style, the GRADE approach for assessment of the quality of evidence, the Delphi method for establishing consensus on the developed recommendations, and the AGREE-II instrument for the assessment of guideline quality and external validation. The current guidelines are cosponsored by the International Hepato-Pancreato-Biliary Association, the Americas Hepato-Pancreato-Biliary Association, the Asian-Pacific Hepato-Pancreato-Biliary Association, the European-African Hepato-Pancreato-Biliary Association, the European Association for Endoscopic Surgery, Pancreas Club, the Society of American Gastrointestinal and Endoscopic Surgery, the Society for Surgery of the Alimentary Tract, and the Society of Surgical Oncology. RESULTS: After screening 16,069 titles, 694 studies were reviewed, and 291 were included. The final 28 recommendations covered 6 topics; laparoscopic and robotic distal pancreatectomy, central pancreatectomy, pancreatoduodenectomy, as well as patient selection, training, learning curve, and minimal annual center volume required to obtain optimal outcomes and patient safety. CONCLUSION: The IG-MIPR using SIGN methodology give guidance to surgeons, hospital administrators, patients, and medical societies on the use and outcome of MIPR as well as the approach to be taken regarding this challenging type of surgery.


Related Papers

No related papers found

Powered by citation graph analysis